Stoxline.com

Stoxline Lite

Stoxline Pro

Option Calculator

iTourMap

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations | Stock Talks | Blogs | Newsletter

 

We are maintaining Chart server, all charts will not be updated untill September 1st.

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Manufacturers - Major

Shares Out. (M)

1660.00

Shares Float (M)

1650.00

% Held by Insiders

0.10

% Held by Institutions

68.70

Shares Short (K)

25390

Shares Short Prior Month (K)

23990

Stock Basics & Statistics

EPS

1.730

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

9.240

PEG Ratio

2.07

Profit Margin

16.59

Operating Margin

20.71

Return on Assets (ttm)

6.0

Return on Equity (ttm)

18.1

Qtrly Rev. Growth

-3.9

Gross Profit (p.s.)

7.090

Sales Per Share

9.765

EBITDA (p.s.)

2.675

Qtrly Earnings Growth

-37.90

Operating Cash Flow (M)

4140.00

Levered Free Cash Flow (M)

3360.00

Valuation

P/E

29.01

P/E Growth Ratio

P/BV

5.43

P/S

5.14

P/CF

20.12

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2014-08-01

Ex-Dividend Date

2014-07-01

Forward Dividend

1.440

Last Split Date

Last Split Ratio

2

 

Enter Stock Symbol:  

Bristol-Myers Squibb Company (BMY)

50.18 +0.19 (+0.38%)

8/22/2014  4:00pm

Open:

49.94

Pre. Close:

49.99

High:

50.25

Low:

49.92

Volume:

4,724,778

Market Cap:

83.194B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

50.32 - 50.72

50.72 - 51.05

Low:

49.04 - 49.47

49.47 - 49.82

Close:

49.59 - 50.2

50.2 - 50.68

Technical analysis  (as of: 2014-08-22 4:30:34 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 59.97     One year: 70.04

Support:

Support1: 49.59    Support2: 48.51

Resistance:

Resistance1: 51.34    Resistance2: 59.97

Pivot:

49.59

Moving Averages:

MA(5): 50.10     MA(20): 49.81

MA(100): 49.02     MA(250): 49.50

MACD:

MACD(12,26): 0.27     Signal(12,26,9): 0.24

%K %D:

%K(14,3): 70.54     %D(3): 63.20

RSI:

RSI(14): 57.80

52-Week:

High: 56.66  Low: 40.15  Change(%): 21.7

Average Vol(K):

3-Month: 7708  10-Days 4625

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BMY has closed below upper band by 19.6%. Bollinger Bands are 43.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 22 Aug 2014 11:07:22 GMT
FDA Grants Label Expansion For Bristol-Myers And Pfizer's Blood-Thinning Drug

Wed, 20 Aug 2014 20:48:45 GMT
Celgene To Work With Bristol-Myers On Various Cancer Treatments

Fri, 22 Aug 2014 20:37:30 GMT
3 Reasons Bristol-Myers Squibb's Stock Could Rise

Thu, 24 Jul 2014 00:56:15 GMT
Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic ...

Mon, 11 Aug 2014 17:53:31 GMT
Analyst Update: Bristol-Myers Squibb Co, Eli Lilly and Co, and Merck & Co., Inc.

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

 
iTouMap

Nova Stocks

Share your ideas ...
Find hot stocks ...

 

(c) 2006-2013 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.